Homeβ€ΊSearchβ€ΊJournal of Hepatocellular Carcinoma

Journal of Hepatocellular Carcinoma

Dove Medical Press Ltd. Β· New Zealand Β· Est. 1942

ISSN2253-5969eISSN2253-5969
SJR Q2βœ“ WOS SCIEβœ“ Scopus / SJRβœ“ DOAJβœ“ Open Access
96
/ 100
High Trust
PubScope credibility score from verifiable indexing & ethics signals
Score Breakdown
β—† WoS flagship (SCIE/SSCI/AHCI)78
βœ“ Corroboration (3 more)+18
Total96
Third-party records Β· how this is calculated Β· Report an error β†’
⚑ Speed vs Prestige
How does this journal balance review speed with impact level?
16
weeks to publish Β· journal-reported
Average Β· vs ~15 wk median
Q2
SJR Rank
Top 50% in field
Impact Factor & Quartile Β· Web of Science (JCR)

βœ“ Indexed in the Web of Science Core Collection (SCIE) β€” Clarivate publishes an official Journal Impact Factor and JCR quartile for this journal.

See the official Impact Factor & quartile on the journal’s page β†—

The Impact Factor & JCR quartile are licensed by Clarivate β€” we link you to the official source instead of reprinting a number that can go out of date. Open metrics below: SCImago Q2. Source: Clarivate Journal Citation Reports.

SJR Scorei
0.809
H-Indexi
45
CiteScore
ViewΒ β†—
Scopus metric Β· on the journal’s page
Total Worksi
999
Total Citationsi
12,319
2yr Mean Citednessi
2.64
Open Impact Factor alternative
Retractions
1
Source: Retraction Watch

Aims & Scope

The Journal of Hepatocellular Carcinoma is an international, peer-reviewed, open access journal. The journal welcomes original research manuscripts, reviews, clinical trial reports, expert opinions and commentaries relating to all aspects of HCC, spanning from basic laboratory research through to clinical and translational research.

General Information

Country / RegionNew Zealand
Primary LanguageEnglish
1st Year Published1942
Annual Volume~ 192 articles / year
StatusActive (last: 2026)
Total Publications999
Publisher OrgDove Medical Press
OA Since2013
Visit Journal Website

Submission Info

Peer ReviewSingle-blind
Review Time~16 weeks
Acceptance Rateβ€”
OA LicenseCC BY, CC BY-NC
OA Rateβ€”

Ethics & Quality

COPE Memberβœ— No
OASPA Memberβœ— No
Not on Predatory Listsβœ“ Yes
Plagiarism Detectionβœ“ Yes

Think.Check.Submit Compliance

9/12 Β· 75%
βœ…
Do you know the journal / publisher?
Dove Medical Press Ltd.
βœ…
Does the journal have a website?
βœ“ Linked
βœ…
Is the ISSN verified?
2253-5969 / 2253-5969
βœ…
Indexed in a trusted database?
WoS, Scopus, DOAJ, PubMed
βœ…
Peer review process documented?
Single-blind
❌
Follows ethical publishing standards (COPE)?
N/A
❌
APC fees clearly disclosed?
N/A
βœ…
Not on predatory/blacklists?
βœ“ Clean
❌
Long-term digital preservation?
N/A
βœ…
Plagiarism detection in place?
Yes
βœ…
Listed in DOAJ (verified OA)?
DOAJ verified
βœ…
Primary language documented?
English

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published
Citations received
14
528
2019
38
1k
2020
120
3.2k
2021
101
1.4k
2022
175
1.8k
2023
182
1.1k
2024
218
453
2025
152
11
2026

Source: OpenAlex Β· Each year’s green bar = citations earned by that year’s papers, counted to date β€” so recent years look lower simply because their papers haven’t had time to be cited yet.

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category β€” its quartile can differ by discipline.

HepatologyQ2
OncologyQ2

Subject Classification

Web of Science Categories

Oncology

Scopus Categories

OncologyHepatology

Research Topics (OpenAlex)

Hepatocellular Carcinoma Treatment and PrognosisCholangiocarcinoma and Gallbladder Cancer StudiesLiver Disease Diagnosis and TreatmentFerroptosis and cancer prognosisCancer Immunotherapy and BiomarkersRadiomics and Machine Learning in Medical ImagingInflammatory Biomarkers in Disease PrognosisCancer Mechanisms and TherapyCancer, Hypoxia, and MetabolismHepatitis B Virus Studies

Frequently asked questions about Journal of Hepatocellular Carcinoma

Is Journal of Hepatocellular Carcinoma a predatory journal?

PubScope has no integrity flags on record for Journal of Hepatocellular Carcinoma: it is indexed in Web of Science, Scopus, DOAJ, and is not on DOAJ's withdrawn list. Its PubScope Trust Score is 96/100. Indexing is a transparency signal, not a guarantee β€” always confirm fit and policies before submitting.

What is the impact factor of Journal of Hepatocellular Carcinoma?

Journal of Hepatocellular Carcinoma is indexed in the Web of Science Core Collection, so Clarivate publishes an official Journal Impact Factor for it (since the 2023 Journal Citation Reports, every Core Collection journal β€” including Arts & Humanities and Emerging Sources titles β€” receives one). PubScope links to Clarivate's official source rather than reprinting the number, which can be out of date. Its open 2-year mean citedness is 2.64.

Is Journal of Hepatocellular Carcinoma indexed in Scopus and Web of Science?

Journal of Hepatocellular Carcinoma is indexed in Web of Science, Scopus, DOAJ.

What is the aims and scope of Journal of Hepatocellular Carcinoma?

The Journal of Hepatocellular Carcinoma is an international, peer-reviewed, open access journal. The journal welcomes original research manuscripts, reviews, clinical trial reports, expert opinions and commentaries relating to all aspects of HCC, spanning from basic laboratory research through to clinical and translational research.

Compare This JournalFind Similar← Back to Search
Understand these signals
How to tell if a journal is predatoryWhat Q1–Q4 quartiles meanWeb of Science vs Scopus vs DOAJWhat is an APC?

Data updated: 2026-05-22 Β· Sources: SJR, DOAJ, OpenAlex, WoS, Crossref